Emerging evidence reveals that pro-tumor TAMs exhibit cancer type-specific molecular signatures (171), with lactate gradients potentially driving their polarization through GPR81-mediated mTORC1 signaling (135). This evidence concerns the gene HCAR1 and neoplasm.